Arora Sandeep, Paul Debatraya, Kumar Richa, Bhatnagar Anuj, Arora Gulhima, Mech Sunita, Suhag Devinder Kumar
Department of Dermatology, Army College of Medical Sciences & Base Hospital Delhi Cantt, India.
Command Hospital Air Force Bangalore, India.
Dermatol Pract Concept. 2022 Jan 1;12(1):e2022010. doi: 10.5826/dpc.1201a10. eCollection 2022 Feb.
Nail involvement in psoriasis may be assessed clinically, ultrasonologically, and dermoscopically. The aim of this study was to assess the dermoscopic features of nails in psoriasis, to compare them with the clinical findings, and to correlate them with the Nail Psoriasis Severity Index (NAPSI) score.
We recruited 120 patients with psoriatic nail changes for the study. The Psoriasis Area Severity Index (PASI) was used to assess the severity of disease. Clinical and dermoscopic (Derm-Lite DL4, ×10, polarized and non-polarized) nail examination determined NAPSI, modified NAPSI (mNAPSI), and NAPSI determined with dermoscopic findings (dermoscopic NAPSI [dNAPSI] and dermoscopic modified NAPSI [dmNAPSI]) were used to assess severity of nail involvement.
Subungual hyperkeratosis (50.8%) and nail plate thickening (56.7%) were the commonest clinical nail changes found, and dermoscopically, they were subungual hyperkeratosis and pitting (68.3% each). The average median with interquartile range of PASI and NAPSI scores were 7.5 [5.7-10.8] and 8.0 [6-12], respectively. NAPSI scores increased significantly with the increase in PASI scores (P < 0.001). A comparison of NAPSI and mNAPSI with dNAPSI and dmNAPSI revealed that NAPSI, mNAPSI, and dNAPSI increased significantly with an increase in PASI scores. The dNAPSI scores increased significantly with increased mNAPSI and dmNAPSI, and mNAPSI and dmNAPSI were significantly good predictors of joint involvement in psoriasis.
Dermoscopy allows for better visualization of nail findings. Evaluating NAPSI and mNAPSI scores in conjunction with dNAPSI and dmNAPSI increases their helps detect early psoriasis, detection of worsening moderate-to-severe psoriasis (PASI >10) and predict joint involvement and their severity.
银屑病的甲损害可通过临床、超声和皮肤镜进行评估。本研究旨在评估银屑病甲的皮肤镜特征,将其与临床发现进行比较,并与甲银屑病严重程度指数(NAPSI)评分相关联。
我们招募了120例有银屑病甲改变的患者进行研究。采用银屑病面积和严重程度指数(PASI)评估疾病严重程度。通过临床和皮肤镜(Derm-Lite DL4,×10,偏振和非偏振)甲检查确定NAPSI、改良NAPSI(mNAPSI)以及根据皮肤镜检查结果确定的NAPSI(皮肤镜NAPSI [dNAPSI]和皮肤镜改良NAPSI [dmNAPSI]),用于评估甲受累的严重程度。
临床最常见的甲改变是甲下角化过度(50.8%)和甲板增厚(56.7%),皮肤镜下则是甲下角化过度和凹点(各占68.3%)。PASI和NAPSI评分的平均中位数及四分位间距分别为7.5 [5.7 - 10.8]和8.0 [6 - 12]。NAPSI评分随PASI评分的增加而显著升高(P < 0.001)。将NAPSI和mNAPSI与dNAPSI和dmNAPSI进行比较发现,NAPSI、mNAPSI和dNAPSI均随PASI评分的增加而显著升高。dNAPSI评分随mNAPSI和dmNAPSI的增加而显著升高,且mNAPSI和dmNAPSI是银屑病关节受累的显著良好预测指标。
皮肤镜可更好地观察甲的表现。联合评估NAPSI和mNAPSI评分以及dNAPSI和dmNAPSI有助于早期发现银屑病,检测中重度银屑病(PASI > 10)的病情恶化,并预测关节受累情况及其严重程度。